Citations (1)
Keep up to date with the latest research on this topic with citation updates for this article.
OncoTargets and Therapy
Volume 15, 2022 - Issue
Case Report
FGFR2-ERC1: A Subtype of FGFR2 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Anlotinib
Chen HongDepartment of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, People’s Republic of China
https://orcid.org/0000-0002-9292-5902View further author information
https://orcid.org/0000-0002-9292-5902View further author information, , , Xia WangDepartment of Oncology, the Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, People’s Republic of Chinahttps://orcid.org/0000-0002-6986-0979View further author information
https://orcid.org/0000-0002-6986-0979View further author information &